Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:873-877
Published online before print October 20, 2003, doi: 10.1161/01.HYP.0000098660.26184.63
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/5/873    most recent
01.HYP.0000098660.26184.63v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grassi, G.
Right arrow Articles by Mancia, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grassi, G.
Right arrow Articles by Mancia, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
*High Blood Pressure
*Obesity
Related Collections
Right arrow Congestive
Right arrow Obesity
Right arrow Clinical Studies
Right arrow Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 2003;42:873.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients

Guido Grassi; Gino Seravalle; Fosca Quarti-Trevano; Raffaella Dell’Oro; Gianbattista Bolla; Giuseppe Mancia

From Clinica Medica, Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie Sanitarie, Università Milano-Bicocca, Centro Interuniversitario di Fisiologia Clinica e Ipertensione and Istituto Auxologico Italiano, Milan, Italy.

Correspondence to Prof Giuseppe Mancia, Clinica Medica, Ospedale S. Gerardo dei Tintori, Via Donizetti 106, 20052 Monza (Mi), Italy. E-mail: giuseppe.mancia{at}unimib.it

Previous studies have shown that congestive heart failure is characterized by sympathetic and reflex dysfunctions. Whether these alterations are potentiated in the presence of obesity and hypertension, two conditions that also display neuroadrenergic abnormalities and markedly increase the risk of heart failure, is unknown. In 14 healthy control subjects (C; age, 55.1±3.0 years; mean±SEM), 13 lean hypertensive subjects (H), 15 obese normotensive subjects (O), 14 lean normotensive subjects with congestive heart failure (CHF, New York Heart Association class II), 14 lean hypertensive subjects with CHF (CHFH), 14 obese normotensive subjects with CHF (CHFO), and 13 obese hypertensive subjects with CHF (CHFOH), all age-matched with C, we measured mean blood pressure (Finapres), heart rate (ECG), and muscle sympathetic nerve traffic (MSNA, microneurography) at rest and during baroreflex testing. Compared with C, body mass index was similarly increased in O, CHFO, and CHFOH, whereas mean blood pressure was similarly increased in HF, CHFH, and CHFOH, and left ventricular ejection fraction (echocardiography) was similarly reduced in CHF, CHFH, CHFO and CHFOH. Compared with C, MSNA was significantly increased in O, H, and CHF (43.0±2.2 versus 54.1±2.8, 53.1±2.5, and 57.4±2.8 bursts/100 heart beats, P<0.01). When O or H was combined with CHF, the MSNA increase was significantly more pronounced and maximal when O and H were concomitantly associated with CHF. Baroreflex sensitivity was reduced in O and H, with a further reduction in CHF and a minimal value in CHFOH. These data show that the sympathetic activation characterizing CHF is markedly potentiated when O and H alone or combined together are associated with a low cardiac output state and that this may depend on an arterial baroreflex impairment.


Key Words: hypertension, essential • obesity • congestive heart failure • sympathetic nervous system • autonomic nervous system • baroreceptors




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. S. Floras
Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.
J. Am. Coll. Cardiol., July 28, 2009; 54(5): 375 - 385.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, G. Seravalle, F. Quarti-Trevano, R. Dell'Oro, F. Arenare, D. Spaziani, and G. Mancia
Sympathetic and Baroreflex Cardiovascular Control in Hypertension-Related Left Ventricular Dysfunction
Hypertension, February 1, 2009; 53(2): 205 - 209.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
G. Grassi, G. Bolla, F. Quarti-Trevano, F. Arenare, G. Brambilla, and G. Mancia
Sympathetic activation in congestive heart failure: Reproducibility of neuroadrenergic markers
Eur J Heart Fail, December 1, 2008; 10(12): 1186 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. D. Abel, S. E. Litwin, and G. Sweeney
Cardiac Remodeling in Obesity
Physiol Rev, April 1, 2008; 88(2): 389 - 419.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. E. Lohmeier, T. M. Dwyer, E. D. Irwin, M. A. Rossing, and R. S. Kieval
Prolonged Activation of the Baroreflex Abolishes Obesity-Induced Hypertension
Hypertension, June 1, 2007; 49(6): 1307 - 1314.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, G. Seravalle, F. Quarti-Trevano, F. Scopelliti, R. Dell'Oro, G. Bolla, and G. Mancia
Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome: Characteristics and Mechanisms
Hypertension, March 1, 2007; 49(3): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Shibao, A. Gamboa, A. Diedrich, A. C. Ertl, K. Y. Chen, D. W. Byrne, G. Farley, S. Y. Paranjape, S. N. Davis, and I. Biaggioni
Autonomic Contribution to Blood Pressure and Metabolism in Obesity
Hypertension, January 1, 2007; 49(1): 27 - 33.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
L. S. Evangelista, D. K. Moser, C. Westlake, M. A. Hamilton, G. C. Fonarow, and K. Dracup
Impact of obesity on quality of life and depression in patients with heart failure
Eur J Heart Fail, November 1, 2006; 8(7): 750 - 755.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Gustafsson, C Torp-Pedersen, M Seibaek, H Burchardt, O W. Nielsen, L Kober, and for the DIAMOND study group
A history of arterial hypertension does not affect mortality in patients hospitalised with congestive heart failure
Heart, October 1, 2006; 92(10): 1430 - 1433.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
P. A. van Zwieten and G. Mancia
Background and treatment of metabolic syndrome: a therapeutic challenge.
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 206 - 214.
[Abstract] [PDF]


Home page
HypertensionHome page
J. Spaak, Z. J. Egri, T. Kubo, E. Yu, S.-I. Ando, Y. Kaneko, K. Usui, T. D. Bradley, and J. S. Floras
Muscle Sympathetic Nerve Activity During Wakefulness in Heart Failure Patients With and Without Sleep Apnea
Hypertension, December 1, 2005; 46(6): 1327 - 1332.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, A. Facchini, F. Q. Trevano, R. Dell'Oro, F. Arenare, F. Tana, G. Bolla, A. Monzani, M. Robuschi, and G. Mancia
Obstructive Sleep Apnea-Dependent and -Independent Adrenergic Activation in Obesity
Hypertension, August 1, 2005; 46(2): 321 - 325.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. W. Gold, M.-L. Wong, D. S. Goldstein, H. K. Gold, D. S. Ronsaville, M. Esler, S. Alesci, A. Masood, J. Licinio, T. D. Geracioti Jr., et al.
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia
PNAS, June 7, 2005; 102(23): 8303 - 8308.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Kaye and M. Esler
Sympathetic neuronal regulation of the heart in aging and heart failure
Cardiovasc Res, May 1, 2005; 66(2): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, A. Vincenti, R. Brambilla, F. Q. Trevano, R. Dell'Oro, A. Ciro, G. Trocino, A. Vincenzi, and G. Mancia
Sustained Sympathoinhibitory Effects of Cardiac Resynchronization Therapy in Severe Heart Failure
Hypertension, November 1, 2004; 44(5): 727 - 731.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. M. Sharma
Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension?
Hypertension, July 1, 2004; 44(1): 12 - 19.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Pilz, J.-H. Brasen, W. Schneider, and F. C. Luft
Obesity and Hypertension-Induced Restrictive Cardiomyopathy: A Harbinger of Things to Come
Hypertension, May 1, 2004; 43(5): 911 - 917.
[Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi and G. Mancia
Neurogenic Hypertension: Is the Enigma of Its Origin Near the Solution?
Hypertension, February 1, 2004; 43(2): 154 - 155.
[Full Text] [PDF]